Physicians are earning more money

At a time when physicians are in high demand, the occupation is seeing rising salaries, according to the latest compensation findings from the Medical Group Management Association (MGMA). In 2018, median compensation rose across the board from the previous year, with specialty physicians seeing a 4.4% increase, primary care physicians’ earnings rising 3.4% and advance practitioners experiencing a 2.9% rise.

The 2019 findings, detailed in MGMA’s Provider Compensation and Production Report, has data from more than 147,000 physicians and non-physician providers in more than 5,500 organizations.

The compensation increases may good news for those in the field, especially as demand is expected to continue rising and total compensation among all providers has risen between 7% and 11% over the last five years. The salary increases are also reflective of the added value that physicians bring to healthcare providers. One recent study found an individual physician can add more than $2 million in revenue at hospitals.

“The increases we are seeing are driven not only by supply and demand but also by an increase in productivity,” said Halee Fischer-Wright, MD, MMM, FAAP, FACMPE, president and CEO at MGMA, said in a statement. “Practices are staying ahead of the curve by monitoring these trends and in this case, offering higher wages and more incentives to attract and retain the talent they need.”

Practices that are in need of physicians are also offering higher salaries to attract their workforce. While compensation rose across the board in 2018, the biggest gains from the previous year were among specialties with the highest shortages, including newly-hired emergency medicine––40.43% ($207,360 to $291,1940­­––cardiology––21.25% ($400,000 to $485,000)––and urology physicians­­––20% ($312,500 to $375,000).

Physician assistant salaries jumped 10.35%, while nurse practitioners saw compensation rise 4%.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.